One-level step section histological analysis is insufficient to confirm complete pathological response after neoadjuvant chemoradiation for rectal cancer
Neoadjuvant chemoradiation therapy (nCRT) for rectal cancer may lead to cure. As we currently lack reliable methods to clinically confirm the absence of disease, some patients undergo radical resection and have pathological complete response (pCR) still undergo surgery. Furthermore, it is uncertain if conventional one-level histopathological analysis is accurate enough to determine complete response. Confirming pCR is essential to determine the prognosis and to consider the patient’s inclusion in trials of adjuvant therapy. The aim of this study was to determine whether the current 1-level approach is sufficient to confirm pCR.
Four hundred and thirty-five patients with rectal cancer who received nCRT followed by radical resection were analyzed. All cases identified as pCR by 1-level step section histological evaluation were reassessed with 3-level step sections and immunohistochemical analysis to verify the presence of residual disease.
Out of 435 patients, 75 (17.2%) were staged as ypT0. Of these, 6 had lymph node involvement and 1 had distant metastasis, leaving 68 (15.6%) who had pCR. After the additional step sections, residual tumor was detected in 12 (17.6%) of these 68. The final pCR rate was 12.9%. Distant recurrence was detected in 7.1% of real-pCR patients compared to 16.7% in the false-pCR group (p = 0.291). Sensitivity of clinical assessment for detecting pCR was 35.7%, and the accuracy of 1-section histological evaluation to identify pCR was 82.4%.
Histopathological analysis with 1-level step section is insufficient to determine complete tumor eradication. The 3-level sections methodology revealed residual tumor cells in patients initially classified as ypT0. Further studies with larger sample size are required to verify the clinical relevance of these residual tumor cells. Caution should continue to be applied to watch and wait strategies following nCRT.
KeywordsRectal cancer Complete response Neoadjuvant therapy Pathologic response Watch and wait
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This study was approved by the hospital ethics committee (Cancer Institute, HCFMUSP-ICESP Ethics Committee: 102/15), and all procedures followed were in accordance with the ethical standards.
For this type of study, formal consent is not required because the analysis used anonymous clinical data that were obtained by a medical database after each patient agreed to treatment by written consent.
- 7.Habr-Gama A, Perez RO, Wynn G, Marks J, Kessler H, Gama-Rodrigues J (2010) Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum 53:1692–1698CrossRefPubMedGoogle Scholar
- 9.Tang LH, Berlin J, Branton P, et al (2013) Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. College of American Pathologists (CAP), ColonRectumGoogle Scholar
- 11.Nahas SC, Rizkallah Nahas CS, Sparapan Marques CF, Ribeiro U Jr, Cotti GC, Imperiale AR, Capareli FC, Chih Chen AT, Hoff PM, Cecconello I (2016) Pathologic complete response in rectal cancer: can we detect it? lessons learned from a proposed randomized trial of watch-and-wait treatment of rectal cancer. Dis Colon Rectum 59(4):255–263. doi: 10.1097/DCR.0000000000000558 CrossRefPubMedGoogle Scholar
- 13.Dias AR, Pereira MA, de Mello ES, Zilberstein B, Cecconelo I, Ribeiro U Jr. (2016) Carnoy’s solution increases the number of examined lymph nodes following gastrectomy for adenocarcinoma: a randomized trial. Gastric Cancer 19(1):136–142. doi: 10.1007/s10120-014-0443-2 (Epub 2014 Nov 20) CrossRefPubMedGoogle Scholar
- 16.Quirke P, Morris E (2007) Reporting colorectal cancer. Histopathology 50(103–11):2Google Scholar
- 19.Loughrey MB, Quirke P, Shepherd NA (2014) Dataset for colorectal cancer histopathology reports, 2nd edn. The Royal College of Pathologists, LondonGoogle Scholar
- 24.Ribeiro U Jr, Alves VA, de Souza PMSB et al (2000) Correlação das proteínas p53 e Ki67 com o prognóstico de pacientes com adenocarcinoma de reto distal. Rev bras Coloproct 20(4):248–256Google Scholar